Posted by Michael Wonder on 30 Nov 2017
FDA approves Ferring’s Clenpiq (sodium picosulfate, magnesium oxide, and anhydrous citric acid) oral solution for colonoscopy prep
29 November 2017 - New ready-to-drink low-volume colonoscopy prep in a pre-mixed liquid solution.
The U.S. FDA has granted Ferring Pharmaceuticals approval to market Clenpiq (sodium picosulfate, magnesium oxide, and anhydrous citric acid) oral solution for cleansing of the colon in adults undergoing a colonoscopy.
With availability planned in Q1 2018, Clenpiq will be the only FDA-approved prescription colonoscopy prep that comes “ready-to-drink”.
